SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-12-348899
Filing Date
2012-08-10
Accepted
2012-08-10 09:24:51
Documents
5
Period of Report
2012-06-12
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K d380594d8ka.htm 8-K/A 28955
2 CONSENT OF PRICEWATERHOUSECOOPERS LLP d380594dex231.htm EX-23.1 1543
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF EUSA PHARMA INC d380594dex991.htm EX-99.1 465386
4 UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF EUSA PHARMA INC d380594dex992.htm EX-99.2 150561
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION d380594dex993.htm EX-99.3 318176
  Complete submission text file 0001193125-12-348899.txt   965745
Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33500 | Film No.: 121022803
SIC: 2834 Pharmaceutical Preparations